Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

EG

Everest Group Appoints Allan Levine to Board

Everest Group, Ltd. (NYSE: EG) has announced the appointment of Allan Levine as an independent, non-executive member of its Board of Directors. Levine brings with him a three-decade career in insurance and financial markets, having served as Co-Founder and Executive Chairman of Global Atlantic, a leading insurance company and wholly owned subsidiary of KKR & Co. Inc.

During his tenure at Global Atlantic, Levine led the firm’s evolution and growth strategy, achieving significant scale across diverse markets globally and managing $190 billion of assets. Prior to that, he was CEO of Goldman Sachs Reinsurance Group, where he played an integral role as Partner and Co-Head of Firm-Wide Strategy. Levine also serves on the Board of the American Council of Life Insurers, the Advisory Board for the Tamer Center for Social Enterprise at Columbia Business School, and the Board of the Nantucket Boys & Girls Club.

Everest Group, Ltd. is known for its disciplined underwriting, capital, and risk management, and is committed to underwriting opportunities for colleagues, customers, shareholders, and communities worldwide. The company's common stock (NYSE: EG) is a component of the S&P 500 index.

The addition of Allan Levine to Everest's Board of Directors comes on the heels of the recent appointments of Darryl Page and John Howard, reflecting the company's commitment to strengthening its leadership team. The company aims to leverage Levine's experience and insights to execute on its long-term strategy and capitalize on the significant potential of its global platform. Following these announcements, the company's shares moved 1.34%, and are now trading at a price of $341.82. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS